Molecular Imaging Without Radiopharmaceuticals?
Open Access
- 14 May 2009
- journal article
- research article
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine
- Vol. 50 (6) , 999-1007
Abstract
The limitations on the sensitivity for detecting small changes in MRI, CT, and ultrasound pulse-echo images are used to estimate the practical requirements for molecular imaging and targeted contrast enhancement for these modalities. These types of imaging are highly unlikely to approach the sensitivity for detecting molecular processes of radionuclear methods, and the prospects for achieving sufficient concentrations of appropriate agents in vivo are poor for several types of applications such as small-molecule targeting of specific receptors. However, using relatively large carrier systems such as particles and liposomes, sufficient concentrations of paramagnetic agents may be delivered to achieve MR-signal changes adequate for detection. The use of higher-resolution MR images will aid the prospects for molecular imaging in small animals. Theoretic considerations also predict that a similar approach, using rather large particles or carriers of materials with a high atomic number, may also be successful for CT, especially with additional developments such as the use of monochromatic x-rays. The prospects of molecular imaging by x-ray imaging may not be as bleak as has been predicted. For ultrasound detection, gas-filled bubbles can provide a sufficient backscattered sound intensity to be detectable at concentrations and sizes not much different from agents designed for these other modalities.Keywords
This publication has 32 references indexed in Scilit:
- Hyperpolarized 13C Lactate, Pyruvate, and Alanine: Noninvasive Biomarkers for Prostate Cancer Detection and GradingCancer Research, 2008
- Chemical Exchange Saturation Transfer Contrast Agents for Magnetic Resonance ImagingAnnual Review of Biomedical Engineering, 2008
- The detection limit of a Gd3+-based T1 agent is substantially reduced when targeted to a protein microdomainMagnetic Resonance Imaging, 2008
- 3D 1H MRSI of brain tumors at 3.0 tesla using an eight‐channel phased‐array head coilJournal of Magnetic Resonance Imaging, 2007
- Towards hyperpolarized 13C-succinate imaging of brain cancerJournal of Magnetic Resonance, 2007
- Theoretical MRI contrast model for exogenous T2 agentsMagnetic Resonance in Medicine, 2007
- Paramagnetic lanthanide complexes as PARACEST agents for medical imagingChemical Society Reviews, 2006
- Tunable, monochromatic X‐rays: An enabling technology for molecular/cellular imaging and therapyJournal of Cellular Biochemistry, 2003
- PARACEST Agents: Modulating MRI Contrast via Water Proton ExchangeAccounts of Chemical Research, 2003
- Molecular imaging in living subjects: seeing fundamental biological processes in a new lightGenes & Development, 2003